AlivaMab Biologics is a contract research organization that helps pharmaceutical and biotech companies discover and engineer antibody-based therapeutics. It uses its proprietary AlivaMab Mouse transgenic strains to rapidly generate fully human antibodies, with platforms for target validation, protein and cell-based engineering, functional assays, epitope and kinetic characterization, and developability assessments. It differentiates itself through an independent, fee-for-service model with flexible engagement and no royalties or milestone obligations, backed by its established transgenic mouse technology and modular discovery platform. Its goal is to help partners move quickly from target to lead antibodies by providing comprehensive, modular discovery services and deep analytical capabilities.
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
San Diego, California
Founded
N/A
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?